To prevent unfair and deceptive acts or practices and the dissemination of false information related to pharmacy benefit management services for prescription drugs, and for other purposes.
Sponsors
Legislative Progress
ReportedReported by Ms. Cantwell, with an amendment
Reported by Ms. Cantwell, with an amendment
Reported by Ms. Cantwell, with an amendment
Reported by Ms. Cantwell, with an amendment
Reported by Ms. Cantwell, with an amendment
Reported by Ms. Cantwell, with an amendment
Reported by Ms. Cantwell, with an amendment
Reported by Ms. Cantwell, with an amendment
Reported by Ms. Cantwell, with an amendment
Reported by Ms. Cantwell, with an amendment
Summary
What This Bill Does
Prohibits pharmacy benefit managers from spread pricing (charging plans more than reimbursing pharmacies) and arbitrary clawbacks of pharmacy payments. Increases prescription drug pricing transparency.
Who Benefits and How
Pharmacies protected from unfair PBM practices. Health plans know true drug costs. Consumers benefit from transparent pricing.
Who Bears the Burden and How
PBMs lose spread pricing revenue. PBM business model disrupted. Compliance requirements increased.
Key Provisions
- Bans spread pricing by PBMs
- Prohibits arbitrary clawbacks of pharmacy reimbursements
- Prevents fee increases to offset federal program changes
Evidence Chain:
This summary is derived from the structured analysis below. See "Detailed Analysis" for per-title beneficiaries/burden bearers with clause-level evidence links.
Primary Purpose
Prohibits unfair PBM practices including spread pricing and clawbacks
Policy Domains
Legislative Strategy
"Eliminate unfair PBM practices through prohibition"
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology